LAB
Standard Biotools IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$402.08M
P/E Ratio
—
EPS
$-0.13
Beta
1.31
52W High
$1.72
52W Low
$0.87
50-Day MA
$0.95
200-Day MA
$1.22
Dividend Yield
—
Profit Margin
90.70%
Forward P/E
—
PEG Ratio
—
About Standard Biotools Inc
Standard Biotools Inc. (LAB) is a leading biotechnology firm focused on advancing genomic analysis and biological research through innovative tools and technologies. The company specializes in the development of high-performance products tailored for laboratories within genomics and proteomics, delivering enhancements in research precision and efficiency. Leveraging proprietary platforms, Standard Biotools accelerates scientific discoveries, positioning itself at the forefront of the rapidly evolving biotechnology sector. With a commitment to addressing the increasing demand for advanced analytical solutions, LAB is well-positioned to support advancements in the life sciences industry.
Fundamentals
| Revenue (TTM) | $86.25M |
| Gross Profit (TTM) | $45.95M |
| EBITDA | $-68.21M |
| Operating Margin | -44.50% |
| Return on Equity | -9.86% |
| Return on Assets | -8.05% |
| Revenue/Share (TTM) | $0.23 |
| Book Value | $1.44 |
| Price-to-Book | 0.72 |
| Price-to-Sales (TTM) | 4.66 |
| EV/Revenue | 2.603 |
| EV/EBITDA | -19.22 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 4.60% |
| Shares Outstanding | $390.37M |
| Float | $210.59M |
| % Insiders | 1.50% |
| % Institutions | 76.98% |
Historical Volatility
HV 10-Day
39.61%
HV 20-Day
41.06%
HV 30-Day
51.70%
HV 60-Day
47.84%
HV Rank
36.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($1.55 target)
1
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026